Helen Sabzevari - Jun 24, 2021 Form 3 Insider Report for Kinnate Biopharma Inc. (KNTE)

Role
Director
Signature
/s/ Mark A. Meltz, attorney-in-fact
Stock symbol
KNTE
Transactions as of
Jun 24, 2021
Transactions value $
$0
Form type
3
Date filed
6/28/2021, 01:02 PM
Previous filing
May 14, 2021
Next filing
Jul 20, 2021

No securities are beneficially owned.